The toxic action of beryllium eompounds has been studied extensively in the last few years. In many such compounds the harmful effect is due to the anion. An example is seen in the case of the double fluoride of sodium and beryllium which is often used in industry. However it is quite certain that the action of such compounds has an action of its own which was observed long ago (Siem, 1886; Comar, 1935) . Its specific effect seems to be on the histiocytes (reticulo-endothelial system), the beryllium ion causing hyperplasia and hypertrophy of these cells thus leading to the granulomata so characteristic of berylliosis. I have lately carried out histological investigations into that property of beryllium to try to establish more precisely the action of beryllium oxide as it is used in the electrometallurgical preparation of beryllium alloys. The researches concerned the reaction of subcutaneous connective tissue and the cells of the peritoneum and lung to dusts of beryllium compounds.
Experimental Method
The beryllium oxide used came from a hydroelectric plant in Savoy. It was of two types, the first being that commonly used in the preparation of alloys. It (1) If the beryllium oxide is free of fluoride the cells show no great change; the nuclei take the dye well and look normal. The histiocytes cling closely to the clusters which appear to be superficially phagocytosed and intracellular. Careful observation, however, shows the boundary which was described earlier between the histiocyte and the cluster (Fig. 4) (Policard, 1949 various fates which all lead to the same result, the disappearance of the granuloma. I have described their various forms of evolution in previous papers (Policard, 1949a, and 1949b) . Briefly they are as follows: (1) Progressive fibrosis with ultimate formation of a small fibrous nodule; (2) transformation of the intra-alveolar cells into " foam cells " ultimately degenerating and freeing the alveoli which become permeable to air once more; and (3) invasion of the cell mass of the granuloma by cells arising like buds from the neighbouring bronchioles with the formation of curious small bronchiolar adenomatous masses. Why a granuloma should follow one course rather than another is still to be determined. Equally unexplained is the observation that such granulomata, which are very characteristic in the lung and subcutaneous tissue, are far less distinct when injections are made intraperitoneally.
Mode of Resorption of Beryllium Oxide
Masses.-In contrast with what happens to particles of coal or silica, those of beryllium oxide are ultimately absorbed and eliminated. These are slow processes. Ten months after injection one may still encounter clusters of beryllium oxide at the point of injection. But they are definitely smaller, as if shrunken.
The morphology of the process is as follows. In the bronchioles a clear space appears, apparently filled with liquid and mucus, between the epithelium and the mass of beryllium oxide which obstructs the lumen. The cluster is set free and bodily evacuated along the bronchus, probably by coughing (Fig. 7) . The clusters of beryllium oxide in the alveoli gradually become scattered and their substance absorbed by the neighbouring histiocytes. These elements then take on curious shapes which show well with van Gieson stain. In the cytoplasm of these hypertrophied cells are seen diffuse globules measuring some 2 to 6 ,u which take the stain like the beryllium oxide in the clusters (Fig. 6) . Though one could not state definitely that these fragments consist of beryllium oxide, it seems likely that they contain it in conjunction with some protein substratum. We are carrying out cytological work on those singular beryllium cells.
And what becomes of the beryllium oxide thus absorbed ? That can hardly be decided precisely at present. Ultimately it seems to be eliminated by the kidney or stored by the liver. It has indeed been possible to demonstrate by spectrographic analysis the presene of beryllium oxide in those two organs. But the stages intervening between the histiocytic cell containing beryllium masses and the kidney or liver are still uncharted. Discussion
The data described above allow of the following considerations. It is a striking fact that beryllium oxide when freed from fluoride has no necrosing effect on either epithelial or connective tissue cells which come in contact with it. It is impossible to state categorically that beryllium oxide has no effect whatsoever and that the cells in contact with it remain absolutely normal. But it is certain that whatever action it has is very slight; the normal aspect ofthe cells is hardly altered. When beryllium oxide contains traces of fluoride, as is the case in the industrial product used, things are different. Those traces become hydrolysed in the tissues and the hydrofluoric acid produced has its well-known action. The mechanism is commonplace. On the other hand beryllium oxide, even when free of fluoride, has a stimulating action on histiocytes. For some distance about its particles the histiocytes show hyperplasia and hypertrophy of a most curious type. This leads to the formation of granulomata which are characteristic of chronic and subacute beryllium lesions. Although the detailed mechanism of that reaction is still unknown, its reality seems beyond doubt. Comar (1935) , in an excellent thesis, which is not generally quoted, concluded that beryllium exerted a stimulating action on the reticulo-endothelial system. Our observations confirm his conclusions.
Where the mode of action itself is concerned the following facts are of some importance. One knows from the work of Klemperer, Miller, and Hill (1949) ; Grier, Hood, and Hoagland (1949) ; DuBois, Cochran, and Mazur (1949) 
